Entering text into the input field will update the search result below

Radius Health's (RDUS) CEO Jesper Høiland on Q3 2017 Results - Earnings Call Transcript

Nov. 02, 2017 11:47 PM ETRadius Health, Inc. (RDUS)
SA Transcripts profile picture
SA Transcripts

Radius Health, Inc. (NASDAQ:RDUS) Q3 2017 Earnings Conference Call November 2, 2017 4:30 PM ET


Barbara Ryan - Investor & Media Relations

Jesper Høiland - President and Chief Executive Officer

David Snow - Chief Commercial Officer

Gary Hattersley - Chief Scientific Officer

Pepe Carmona - Chief Financial Officer

Bruce Mitlak - VP, Clinical Development


Jessica Fye - JPMorgan

Salveen Richter - Goldman Sachs

Ying Huang - Bank of America Merrill Lynch

Chris Shibutani - Cowen & Co.

Eun Yang - Jefferies & Co.

Mara Goldstein - Cantor Fitzgerald


Good morning everyone and welcome to Radius Health's Third Quarter 2017 Results and Business Update. Today’s call is being recorded.

At this time I’d like to turn the call over to Alex Fudukidis of Radius Health, Investor & Media Relations team. Please begin.

Barbara Ryan

Thank you, Brian. Good afternoon, and thank you for joining us on the conference call and webcast for Radius's third quarter 2017 financial results and business update.

Joining me today are Jesper Høiland, President and Chief Executive Officer; David Snow, our Chief Commercial Officer; Gary Hattersley, our Chief Scientific Officer; and Pepe Carmona, our Chief Financial Officer. In addition Bruce Mitlak, Radius's Vice President of Clinical Development joins us for the Q&A portion of the call.

Before we begin, I would like to remind you that statements made during this call that are not historical facts are considered to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these statements as a result of various important factors, including those discussed in the Risk Factors section of the quarterly report on Form 10-Q for the period ended June 30, 2017 and other reports filed with the Securities and Exchange Commission. Any forward-looking statements represent our

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.